BioCentury
ARTICLE | Strategy

How Xenova has built its group

June 16, 1997 7:00 AM UTC

A number of the large-cap biotech companies have spun off separate entities to maintain the entrepreneurial spirit of self-contained groups. But some smaller biotech companies also are creating sometimes complex business structures.

The recent creation of Xenova Discovery Ltd. adds a third leg to the configuration at parent company Xenova Group plc (XNVAY, Slough, U.K.). Underneath XNVAY lies its Xenova Ltd. operating division, which conducts preclinical and therapeutic activities in the U.K., and Xenova U.K. Ltd., a holding company that owns 70 percent of MetaXen LLC, a drug discovery operation in the U.S...